Stanley A. Kim, Ph.D., J.D.

Dr. Kim, STROX’s founder, President, and Chief Executive Officer, obtained his Ph.D. in Microbiology and Immunology from the University of Miami in 1993.  He subsequently obtained his JD in 1998 from Suffolk University, where he graduated at the top of his class.  A registered patent attorney, Dr. Kim has over 15 years experience in intellectual property law and counseling entrepreneurial companies.  Dr. Kim also co-founded Nautilus Biosciences Canada Inc. - a private Canadian company that has raised several million dollars to develop marine-derived small molecule drugs; WhatItCosts.com - an online leader in providing information on the costs associated with a wide variety of services and concepts; and ASE Pharmaceuticals - a private company developing drugs for treating neurologic pathologies.  

Paul M. Herron, MBA

Mr. Herron serves as the Chief Financial Officer of STROX.   He is an accomplished corporate finance and business development executive with extensive experience in the biopharmaceutical industry.  His corporate finance experience spans more than 30 years, beginning with E.I. duPont de Nemours & Co. in 1976.   Mr. Herron entered the biopharmaceutical field in 1987 as a senior business analyst for DuPont’s nuclear medicine business, later serving as finance manager for two operating businesses in DuPont’s joint venture with Merck.  Over the past 12 years, he has served as Chief Financial Officer in three early-stage biopharmaceutical companies, and most recently as Vice President for Business Development for an emerging immunotherapeutics company, where he initiated a comprehensive corporate partnering effort, closed two financing rounds, and negotiated several key licensing agreements.